The Walden Group is pleased to provide access to an Interim Healthcare Industry Report providing a window into how the healthcare industry is taking steps to resume some semblance of normality. It discusses how medical practices and hospitals are carefully opening up, compliant with Covid-19 safety guidelines.
It unpacks the effect of the pandemic...
Select M&A Deals and Terminations in the Age of Coronavirus
(Terms not announced unless specified)
Beaver-Visitec Acquires Ophthalmic Viscoelastic Device Assets from Croma-Pharma (Austria)
Smiths Medical Acquires Access Scientific (US)
Zhuhai Baolian Asset Management Plans to Acquire Shanghai Kehua Bio-Engineering (China)...
The Walden Group, an M&A advisory firm focused on the healthcare industry, has published its complimentary 2020 Q1 Strategic Healthcare M&A Report, available for download on its website, www.waldenmed.com. The report includes analysis of more than 60 M&A transactions announced of closed in Q1, among several other key developments...
In early December 2019, two of the biggest pharmaceutical companies announced multibillion-dollar deals aiming at bolstering their oncology pipeline.
Merck & Co. Inc. is paying $2.5b to acquire ArQule, Inc, whose lead investigational candidate is an oral Bruton’s tyrosine kinase (BTK) inhibitor currently in a Phase II dose-expansion...
Stryker recently announced purchase of Wright Medical for $4b purchase (4.5x revenue and 38.5x EBITDA) is yet another example of the consolidation within the orthopedic and spine sectors. As reimbursement levels become tighter and margins are challenged, economies of scale become paramount.
Wright Medical is a recognized leader in upper...